                         SEQUENCE LISTING

<110>  Oregon Health & Science University
       The United States Government as represented by The 
       Department of Veterans Affairs
       University of Maryland, Baltimore
       Vandenbark, Arthur A.
       Meza-Romero, Roberto
       Alexander, Richard
       Klyushnenkova, Elena
 
<120>  RECOMBINANT T CELL RECEPTOR LIGAND COMPOSITIONS AND METHODS FOR 
       TREATMENT OF PROSTATE CANCER

<130>  899-96298-02

<150>  US 62/276,709
<151>  2016-01-08

<160>  17    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  1

Gly Val Leu Gln Gly Ile Thr Ser Trp Gly Ser Glu Pro Cys Ala Leu 
1               5                   10                  15      


Pro Glu Arg Pro 
            20  


<210>  2
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  2

Gly Val Leu Gln Gly Ile Thr Ser Trp Gly Ser Glu Pro Ser Ala Leu 
1               5                   10                  15      


Pro Glu Arg Pro 
            20  


<210>  3
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  3

Leu Gln Cys Val Asp Leu His Val Ile Ser Asn Asp Val Cys Ala Gln 
1               5                   10                  15      


Val His Pro Gln 
            20  


<210>  4
<211>  175
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  4

Pro Arg Phe Leu Trp Gln Pro Lys Arg Glu Cys His Phe Phe Asn Gly 
1               5                   10                  15      


Thr Glu Arg Val Arg Phe Leu Asp Arg Tyr Phe Tyr Asn Gln Glu Glu 
            20                  25                  30          


Ser Val Arg Phe Asp Ser Asp Val Gly Glu Phe Arg Ala Val Thr Glu 
        35                  40                  45              


Leu Gly Arg Pro Asp Ala Glu Tyr Trp Asn Ser Gln Lys Asp Ile Leu 
    50                  55                  60                  


Glu Gln Ala Arg Ala Ala Val Asp Thr Tyr Cys Arg His Asn Tyr Gly 
65                  70                  75                  80  


Val Val Glu Ser Phe Thr Val Gln Arg Arg Val Ile Lys Glu Glu His 
                85                  90                  95      


Asp Ile Asp Gln Asp Glu Asp Tyr Asp Asn Pro Asp Gln Ser Gly Glu 
            100                 105                 110         


Phe Met Phe Asp Phe Asp Gly Asp Glu Ile Phe His Val Asp Met Ala 
        115                 120                 125             


Lys Lys Glu Thr Val Trp Arg Leu Glu Glu Phe Gly Arg Phe Ala Ser 
    130                 135                 140                 


Phe Glu Ala Gln Gly Ala Leu Ala Asn Ile Ala Val Asp Lys Ala Asn 
145                 150                 155                 160 


Leu Glu Ile Met Thr Lys Arg Ser Asn Tyr Thr Pro Ile Thr Asn 
                165                 170                 175 


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide linker

<400>  5

Gly Gly Gly Gly Ser Leu Val Pro Arg Gly Ser Gly Gly Gly Gly 
1               5                   10                  15  


<210>  6
<211>  211
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  6

Met Gly Val Leu Gln Gly Ile Thr Ser Trp Gly Ser Glu Pro Cys Ala 
1               5                   10                  15      


Leu Pro Glu Arg Pro Gly Gly Gly Gly Ser Leu Val Pro Arg Gly Ser 
            20                  25                  30          


Gly Gly Gly Gly Pro Arg Phe Leu Trp Gln Pro Lys Arg Glu Cys His 
        35                  40                  45              


Phe Phe Asn Gly Thr Glu Arg Val Arg Phe Leu Asp Arg Tyr Phe Tyr 
    50                  55                  60                  


Asn Gln Glu Glu Ser Val Arg Phe Asp Ser Asp Val Gly Glu Phe Arg 
65                  70                  75                  80  


Ala Val Thr Glu Leu Gly Arg Pro Asp Ala Glu Tyr Trp Asn Ser Gln 
                85                  90                  95      


Lys Asp Ile Leu Glu Gln Ala Arg Ala Ala Val Asp Thr Tyr Cys Arg 
            100                 105                 110         


His Asn Tyr Gly Val Val Glu Ser Phe Thr Val Gln Arg Arg Val Ile 
        115                 120                 125             


Lys Glu Glu His Asp Ile Asp Gln Asp Glu Asp Tyr Asp Asn Pro Asp 
    130                 135                 140                 


Gln Ser Gly Glu Phe Met Phe Asp Phe Asp Gly Asp Glu Ile Phe His 
145                 150                 155                 160 


Val Asp Met Ala Lys Lys Glu Thr Val Trp Arg Leu Glu Glu Phe Gly 
                165                 170                 175     


Arg Phe Ala Ser Phe Glu Ala Gln Gly Ala Leu Ala Asn Ile Ala Val 
            180                 185                 190         


Asp Lys Ala Asn Leu Glu Ile Met Thr Lys Arg Ser Asn Tyr Thr Pro 
        195                 200                 205             


Ile Thr Asn 
    210     


<210>  7
<211>  644
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleic acid construct

<400>  7
ccatgggtgt gcttcaaggt atcacgtcat ggggcagtga accatgtgcc ctgcccgaaa       60

ggcctggagg tggaggctca ctagtgcccc gaggctctgg aggtggaggc ccacgtttcc      120

tgtggcagcc taagagggag tgtcatttct tcaatgggac ggagcgggtg cggttcctgg      180

acagatactt ctataaccag gaggagtccg tgcgcttcga cagcgacgtg ggggagttcc      240

gggcggtgac ggagctgggg cggcctgacg ctgagtactg gaacagccag aaggacatcc      300

tggagcaggc gcgggccgcg gtggacacct actgcagaca caactacggg gttgtggaga      360

gcttcacagt gcagcggcga gtcatcaaag aagaacatga catcgaccag gacgaggact      420

atgacaatcc tgaccaatca ggcgagttta tgtttgactt tgatggtgat gagattttcc      480

atgtggatat ggcaaagaag gagacggtct ggcggcttga agaatttgga cgatttgcca      540

gctttgaggc tcaaggtgca ttggccaaca tagctgtgga caaagccaac ttggaaatca      600

tgacaaagcg ctccaactat actccgatca ccaattaact cgag                       644


<210>  8
<211>  211
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  8

Met Gly Val Leu Gln Gly Ile Thr Ser Trp Gly Ser Glu Pro Ser Ala 
1               5                   10                  15      


Leu Pro Glu Arg Pro Gly Gly Gly Gly Ser Leu Val Pro Arg Gly Ser 
            20                  25                  30          


Gly Gly Gly Gly Pro Arg Phe Leu Trp Gln Pro Lys Arg Glu Cys His 
        35                  40                  45              


Phe Phe Asn Gly Thr Glu Arg Val Arg Phe Leu Asp Arg Tyr Phe Tyr 
    50                  55                  60                  


Asn Gln Glu Glu Ser Val Arg Phe Asp Ser Asp Val Gly Glu Phe Arg 
65                  70                  75                  80  


Ala Val Thr Glu Leu Gly Arg Pro Asp Ala Glu Tyr Trp Asn Ser Gln 
                85                  90                  95      


Lys Asp Ile Leu Glu Gln Ala Arg Ala Ala Val Asp Thr Tyr Cys Arg 
            100                 105                 110         


His Asn Tyr Gly Val Val Glu Ser Phe Thr Val Gln Arg Arg Val Ile 
        115                 120                 125             


Lys Glu Glu His Asp Ile Asp Gln Asp Glu Asp Tyr Asp Asn Pro Asp 
    130                 135                 140                 


Gln Ser Gly Glu Phe Met Phe Asp Phe Asp Gly Asp Glu Ile Phe His 
145                 150                 155                 160 


Val Asp Met Ala Lys Lys Glu Thr Val Trp Arg Leu Glu Glu Phe Gly 
                165                 170                 175     


Arg Phe Ala Ser Phe Glu Ala Gln Gly Ala Leu Ala Asn Ile Ala Val 
            180                 185                 190         


Asp Lys Ala Asn Leu Glu Ile Met Thr Lys Arg Ser Asn Tyr Thr Pro 
        195                 200                 205             


Ile Thr Asn 
    210     


<210>  9
<211>  644
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleic acid construct

<400>  9
ccatgggtgt gcttcaaggt atcacgtcat ggggcagtga accatcagcc ctgcccgaaa       60

ggcctggagg tggaggctca ctagtgcccc gaggctctgg aggtggaggc ccacgtttcc      120

tgtggcagcc taagagggag tgtcatttct tcaatgggac ggagcgggtg cggttcctgg      180

acagatactt ctataaccag gaggagtccg tgcgcttcga cagcgacgtg ggggagttcc      240

gggcggtgac ggagctgggg cggcctgacg ctgagtactg gaacagccag aaggacatcc      300

tggagcaggc gcgggccgcg gtggacacct actgcagaca caactacggg gttgtggaga      360

gcttcacagt gcagcggcga gtcatcaaag aagaacatga catcgaccag gacgaggact      420

atgacaatcc tgaccaatca ggcgagttta tgtttgactt tgatggtgat gagattttcc      480

atgtggatat ggcaaagaag gagacggtct ggcggcttga agaatttgga cgatttgcca      540

gctttgaggc tcaaggtgca ttggccaaca tagctgtgga caaagccaac ttggaaatca      600

tgacaaagcg ctccaactat actccgatca ccaattaact cgag                       644


<210>  10
<211>  210
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  10

Leu Gln Cys Val Asp Leu His Val Ile Ser Asn Asp Val Cys Ala Gln 
1               5                   10                  15      


Val His Pro Gln Gly Gly Gly Gly Ser Leu Val Pro Arg Gly Ser Gly 
            20                  25                  30          


Gly Gly Gly Pro Arg Phe Leu Trp Gln Pro Lys Arg Glu Cys His Phe 
        35                  40                  45              


Phe Asn Gly Thr Glu Arg Val Arg Phe Leu Asp Arg Tyr Phe Tyr Asn 
    50                  55                  60                  


Gln Glu Glu Ser Val Arg Phe Asp Ser Asp Val Gly Glu Phe Arg Ala 
65                  70                  75                  80  


Val Thr Glu Leu Gly Arg Pro Asp Ala Glu Tyr Trp Asn Ser Gln Lys 
                85                  90                  95      


Asp Ile Leu Glu Gln Ala Arg Ala Ala Val Asp Thr Tyr Cys Arg His 
            100                 105                 110         


Asn Tyr Gly Val Val Glu Ser Phe Thr Val Gln Arg Arg Val Ile Lys 
        115                 120                 125             


Glu Glu His Asp Ile Asp Gln Asp Glu Asp Tyr Asp Asn Pro Asp Gln 
    130                 135                 140                 


Ser Gly Glu Phe Met Phe Asp Phe Asp Gly Asp Glu Ile Phe His Val 
145                 150                 155                 160 


Asp Met Ala Lys Lys Glu Thr Val Trp Arg Leu Glu Glu Phe Gly Arg 
                165                 170                 175     


Phe Ala Ser Phe Glu Ala Gln Gly Ala Leu Ala Asn Ile Ala Val Asp 
            180                 185                 190         


Lys Ala Asn Leu Glu Ile Met Thr Lys Arg Ser Asn Tyr Thr Pro Ile 
        195                 200                 205             


Thr Asn 
    210 


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  11

His Cys Ile Arg Asn Lys Ser Val Ile 
1               5                   


<210>  12
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  12

Ser Ser Pro Val Asn Ser Leu Arg Asn Val Val 
1               5                   10      


<210>  13
<211>  175
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  13

Pro Arg Phe Leu Trp Gln Pro Lys Arg Glu Cys His Phe Phe Asn Gly 
1               5                   10                  15      


Thr Glu Arg Val Arg Phe Leu Asp Arg Tyr Phe Tyr Asn Gln Glu Glu 
            20                  25                  30          


Ser Val Arg Phe Asp Ser Asp Val Gly Glu Phe Arg Ala Val Thr Glu 
        35                  40                  45              


Leu Gly Arg Pro Asp Ala Glu Tyr Trp Asn Ser Gln Lys Asp Ile Leu 
    50                  55                  60                  


Glu Gln Ala Arg Ala Ala Val Asp Thr Tyr Cys Arg His Asn Tyr Gly 
65                  70                  75                  80  


Val Val Glu Ser Phe Thr Val Gln Arg Arg Val Ile Lys Glu Glu His 
                85                  90                  95      


Val Ile Ile Gln Ala Glu Phe Tyr Leu Asn Pro Asp Gln Ser Gly Glu 
            100                 105                 110         


Phe Met Phe Asp Phe Asp Gly Asp Glu Ile Phe His Val Asp Met Ala 
        115                 120                 125             


Lys Lys Glu Thr Val Trp Arg Leu Glu Glu Phe Gly Arg Phe Ala Ser 
    130                 135                 140                 


Phe Glu Ala Gln Gly Ala Leu Ala Asn Ile Ala Val Asp Lys Ala Asn 
145                 150                 155                 160 


Leu Glu Ile Met Thr Lys Arg Ser Asn Tyr Thr Pro Ile Thr Asn 
                165                 170                 175 


<210>  14
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  14

Lys Lys Leu Gln Cys Val Asp Leu His Val Ile Ser Asn 
1               5                   10              


<210>  15
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  15

Gly Val Leu Gln Gly Ile Thr Ser Trp Gly Ser Glu Pro 
1               5                   10              


<210>  16
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  16

Leu Gln Cys Val Asp Leu His Val Ile 
1               5                   


<210>  17
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  17

Leu Gln Gly Ile Thr Ser Trp Gly Ser 
1               5                   


